Emsita Trio 10mg/500mg/100mg Tablet ER: Comprehensive Diabetes Management

Emsita Trio 10mg/500mg/100mg Tablet ER is a once-daily extended-release combination medication designed for the treatment of adults with type 2 diabetes mellitus. This formulation contains a precise blend of dapagliflozin (10 mg), metformin (500 mg), and sitagliptin (100 mg).

How it Works:
Emsita Trio combines the action of three key medications to help manage blood glucose levels effectively:

* Dapagliflozin: Helps lower blood sugar by increasing glucose excretion through the kidneys.
* Metformin: Lowers blood sugar primarily by reducing hepatic glucose production and enhancing insulin sensitivity.
* Sitagliptin: Works by inhibiting the action of dipeptidyl peptidase-4 (DPP-4), which regulates the release of incretin hormones, promoting a reduction in blood sugar.

Benefits:
Emsita Trio provides comprehensive type 2 diabetes management with:

* Once-daily administration for convenience and adherence.
* A proven track record of effectiveness in achieving glycemic control.

Consult your doctor or pharmacist for personalized recommendations regarding this medication.